Singlepoint Healthcare

What Singlepoint Healthcare does

Singlepoint Healthcare is a privately held, PE-backed specialty care services platform founded in July 2025 and headquartered in Columbus, Ohio, focused on integrated care delivery for patients with inflammatory and autoimmune diseases across neurology, rheumatology, and immunology. The company was launched with backing from DFW Capital Partners and has executed three acquisitions in its first year: The Boster Center for Multiple Sclerosis (July 2025), IV Solutions (August 2025), and Healix (June 2026). Through these acquisitions, Singlepoint operates company-owned specialty clinics in Columbus, OH and Wood Dale, IL, provides home infusion therapy in the Chicagoland area, and via Healix supports more than 220 physician-owned and ambulatory infusion centers across the United States.

The platform delivers five core clinical service lines — specialty care visits, infusion and injection services, clinical research, spasticity management, and care coordination — delivered through three acquired brands that retain their identities: The Boster Center (nationally recognized MS specialty practice led by Dr. Aaron Boster), IV Solutions (CHAP-accredited home infusion provider established in 2001), and Healix (35-year-old national outpatient infusion management and pharmacy services company). The core technology is the integrated care delivery model itself rather than a software platform: Singlepoint coordinates multi-specialty clinical care with high-need ancillary services (infusion, specialty pharmacy, clinical research) through a single point of access. No proprietary AI or software product is disclosed; website integrations are limited to Google Analytics, reCAPTCHA, and Google Maps.

The revenue model is services-based: Singlepoint generates revenue through outpatient clinical visits, infusion and injection therapy administration, specialty pharmacy services, home infusion (via IV Solutions), infusion management contracts (via Healix), and clinical research participation. The company does not publicly disclose pricing, which is typically determined by treatment type, insurance coverage, and patient-specific factors. Go-to-market is sales-led, relying on physician referrals, provider partnerships, patient advocacy communities, and content marketing (notably Dr. Boster's extensive MS education video library and podcast presence) to drive patient acquisition into the integrated care platform. The customer base is patients living with chronic inflammatory conditions such as multiple sclerosis, neuromyelitis optica, myasthenia gravis, MOG antibody disease, chronic migraines, and related neuroinflammatory disorders.

Name

Singlepoint Healthcare

Legal name

Singlepoint Healthcare Inc.

Website

https://singlepointhc.com

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

11–50 employees

Short description

Singlepoint Healthcare is a PE-backed specialty care platform providing integrated neurology, rheumatology, and immunology services for patients with inflammatory diseases, operating clinics in Ohio and Illinois and supporting 220+ infusion centers nationally through its Healix subsidiary.

Ownership category

akta.pro rank

Headquarters

HQ city

Columbus

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Specialty Care Services: Singlepoint Healthcare generates revenue through providing integrated specialty care services for patients with inflammatory diseases. This includes outpatient clinical visits, infusion and injection therapies, and specialty pharmacy services delivered through its network of physician-owned and ambulatory infusion centers.
2. Home Infusion Therapy: The company provides home infusion services through IV Solutions, offering medication therapies, symptom management, and chronic condition care in patients' homes. This expands revenue streams beyond clinic-based care.
3. Clinical Research: Singlepoint Healthcare conducts clinical trials and research studies, particularly at The Boster Center for Multiple Sclerosis, providing access to cutting-edge treatments while contributing to medical advancement.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Singlepoint Healthcare provides integrated specialty care for patients with inflammatory and autoimmune diseases, with current emphasis on multiple sclerosis and related neuroinflammatory conditions. Its core services include specialty care visits, infusion and injection therapy, clinical research, spasticity management, and care coordination, delivered through company-owned clinics, CHAP-accredited home infusion (IV Solutions), and a national network of 220+ physician-owned and ambulatory infusion centers (Healix).

Product overview

Singlepoint Healthcare is a specialty care company providing comprehensive, integrated care for people living with inflammatory diseases. The company operates a platform-plus-services model combining multi-specialty network (neurology, rheumatology, immunology) with high-need ancillary services including infusion therapy, specialty pharmacy, clinical research, and care coordination. The portfolio consists of core clinical services (Specialty Care Visits, Infusion and Injection Services, Clinical Research, Spasticity Management, Care Coordination) delivered through owned/acquired brands including The Boster Center for Multiple Sclerosis (MS specialty practice in Columbus, OH), IV Solutions (home infusion therapy in Chicagoland), and Healix (national outpatient infusion management with 220+ centers). The company was founded in 2025 and is backed by DFW Capital Partners.

Differentiator

Problem solved

Functional benefit

Brands

• The Boster Center for Multiple Sclerosis: A nationally recognized MS specialty practice located in Columbus, Ohio, offering comprehensive multiple sclerosis care and treatment.
• IV Solutions
• Healix

Products and services

• Specialty Care Visits Specialty care visits connecting patients with expert neurology providers who specialize in managing complex inflammatory and autoimmune conditions, with current focus on multiple sclerosis, neuromyelitis optica, and migraines at the founding Columbus, OH location.
• Infusion and Injection Services Advanced infusion and injection therapy services for complex or chronic conditions, including in-office infusion therapy at clinical locations, home infusion therapy through IV Solutions, and outpatient infusion management across 220+ centers via Healix.
• Clinical Research Clinical research program offering a portfolio of studies covering conditions such as multiple sclerosis, providing patients access to cutting-edge treatments while contributing to medical science advancement.
• Spasticity Management Personalized care for muscle stiffness and involuntary contractions, including treatments such as intrathecal Baclofen pumps, oral Baclofen, BOTOX injections, and physical or occupational therapy.
• Care Coordination Streamlined communication between specialists and primary care physicians, coordinating all aspects of treatment from first visit through follow-up care across the integrated platform.

Quantifiable outcome

• Reduced care fragmentation and improved healthcare outcomes through integrated specialty care delivery

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Partnerships

Four partnerships are on record, tiered core and minor.

• HealixcoreStrategic or Co-development Partner · 1 June 2026Acquired by Singlepoint Healthcare in June 2026. Healix is a premier provider of outpatient infusion management and pharmacy services based in Sugar Land, Texas, with more than 35 years of experience. Healix manages over 220 physician-owned and ambulatory infusion centers across the United States, specializing in infectious disease, gastroenterology, neurology, rheumatology, allergy, immunology, and pulmonology. This acquisition marks Singlepoint's third acquisition in the past year and significantly expands national infusion capabilities.
• IV SolutionscoreStrategic or Co-development Partner · 1 August 2025Acquired by Singlepoint Healthcare in 2025. IV Solutions is a provider of clinical pharmacy and home infusion services based in Wood Dale, Illinois, established in 2001 and CHAP-accredited. The company specializes in bringing clinical infusion care into patient homes, serving the Chicagoland area. IV Solutions strengthens Singlepoint's integrated model by adding home infusion capabilities and clinical pharmacy expertise.
• The Boster Center for Multiple SclerosiscoreStrategic or Co-development Partner · 1 July 2025Acquired by Singlepoint Healthcare in July 2025 as part of the company's founding strategy. The Boster Center is a nationally recognized MS specialty practice in Columbus, Ohio, led by Dr. Aaron Boster. It provides comprehensive multiple sclerosis care including specialty visits, infusion services, and clinical research. This acquisition established Singlepoint's initial platform and access to specialized MS expertise.
• Real Talk MSminorGTM or Marketing PartnerSinglepoint Healthcare's Dr. Aaron Boster appears as a guest on the Real Talk MS podcast, discussing clinical trials and MS topics. This partnership supports patient education and extends Singlepoint's reach within the MS community through established podcast content.

Scale indicators5 records

Recent moves5 records

Expansion highlights2 records

Direct peers

• Option Care Health: Largest independent provider of home and alternate-site infusion services in the U.S. Direct competitor to IV Solutions and Healix in specialty home and ambulatory infusion, with overlapping therapy areas in neurology, immunology, and infectious disease.
• Infusion Associates: Outpatient infusion center operator previously led by Singlepoint's CEO and COO. Direct predecessor and comparable specialty infusion platform with overlapping therapy focus on MS and chronic inflammatory conditions.
• Soleo Health: Specialty infusion and pharmacy services provider focused on complex chronic conditions including MS, immunology, and rheumatology. Direct competitor in specialty home infusion and chronic condition management.
• Coram CVS Specialty Infusion Services: CVS Health's specialty home infusion subsidiary offering nationwide home IV therapy across multiple chronic conditions. Direct competitor to IV Solutions and Healix with national reach and integrated specialty pharmacy.

Broad incumbents

• Accredo (Cigna / Evernorth Specialty Pharmacy): Large specialty pharmacy and home infusion provider owned by Cigna/Evernorth. Competes with Singlepoint's specialty pharmacy and home infusion services, particularly in MS and immunology.
• Walgreens Specialty Pharmacy (formerly Walgreens Infusion Services): National specialty pharmacy and infusion services division of Walgreens. Broad incumbent offering home infusion, specialty pharmacy, and care coordination across chronic conditions overlapping Singlepoint's therapy areas.
• UnitedHealth Group / Optum Specialty Infusion: Vertical payer-provider with specialty pharmacy and home infusion capabilities embedded in Optum. Competes on integrated specialty management and could constrain Singlepoint's payer contracting leverage.

Emerging players

• Vital Care Infusion Services: Franchise-based network of outpatient home infusion pharmacies. Comparable to Healix's physician-owned center model with multi-state ambulatory infusion reach.
• National Infusion Center: Ambulatory infusion center operator partnering with physicians to deliver in-office biologic infusions. Closely comparable to Healix's physician-owned center model in therapy areas such as rheumatology and immunology.

Regional players

• MMS (Medical Marketing Solutions) / Metro Infusion Center: Multi-state ambulatory infusion network offering in-office biologics for chronic conditions. Comparable to Singlepoint's clinic-based infusion offering with regional geographic concentration.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/singlepoint-healthcare

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries5 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Singlepoint Healthcare